A screening assay for detecting CD8+ cell non-cytotoxic anti-HIV responses

Journal of Immunological Methods

Volumn 304, Issue 1-2, 2005, Pages 137-150

  Killian, M Scott ^a   Ng, Sharon ^a   Mackewicz, Carl E ^a   Levy, Jay A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiviral; Assay; CD8+ lymphocyte; CNAR; HIV; Immune response; Innate

Indexed keywords

CD8 ANTIGEN;

ARTICLE; CELL NON CYTOTOXIC ANTIVIRAL RESPONSE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; PRIORITY JOURNAL; SCREENING;

CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIV; HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MASS SCREENING; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 24344490275     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.07.016     Document Type: Article

References (51)

1. E. Barker, C.E. Mackewicz, and J.A. Levy Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival Proc. Natl. Acad. Sci. U. S. A. 92 1995 11135
2. E. Barker, K.N. Bossart, S.H. Fujimura, and J.A. Levy CD28 costimulation increases CD8+ cell suppression of HIV replication J. Immunol. 159 1997 5123
3. E. Barker, K.N. Bossart, and J.A. Levy Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines Proc. Natl. Acad. Sci. U. S. A. 95 1998 1725
4. E. Barker, C.E. Mackewicz, G. Reyes-Teran, A. Sato, S.A. Stranford, S.H. Fujimura, C. Christopherson, S.Y. Chang, and J.A. Levy Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome Blood 92 1998 3105
5. D.J. Blackbourn, C.E. Mackewicz, E. Barker, T.K. Hunt, B. Herndier, A.T. Haase, and J.A. Levy Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals Proc. Natl. Acad. Sci. U. S. A. 93 1996 13125
6. J.C. Castelli, S.G. Deeks, S. Shiboski, and J.A. Levy Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals Blood 99 2002 4225
7. R.C. Castillo, S. Arango-Jaramillo, R. John, K. Weinhold, P. Kanki, L. Carruth, and D.H. Schwartz Resistance to human immunodeficiency virus type 1 in vitro as a surrogate of vaccine-induced protective immunity J. Infect. Dis. 181 2000 897
8. B.A. Castro, C.D. Weiss, L.D. Wiviott, and J.A. Levy Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells J. Clin. Microbiol. 26 1988 2371
9. B.K. Chen, R.T. Gandhi, and D. Baltimore CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef J. Virol. 70 1996 6044
10. S.G. Deeks, F.M. Hecht, M. Swanson, T. Elbeik, R. Loftus, P.T. Cohen, and R.M. Grant HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy AIDS 13 1999 F35
11. R. Detels, A. Munoz, G. McFarlane, L.A. Kingsley, J.B. Margolick, J. Giorgi, L.K. Schrager, and J.P. Phair Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators JAMA 280 1998 1497
12. L.S. Diaz, H. Foster, M.R. Stone, S. Fujimura, D.A. Relman, and J.A. Levy VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity J. Immunol. 174 2005 1574
13. J.V. Giorgi, P.G. Nishanian, I. Schmid, L.E. Hultin, H.L. Cheng, and R. Detels Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection J. Clin. Immunol. 7 1987 140
14. A.M. Gomez, F.M. Smaill, and K.L. Rosenthal Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease Clin. Exp. Immunol. 97 1994 68
15. B. Guy, M.P. Kieny, Y. Riviere, C. Le Peuch, K. Dott, M. Girard, L. Montagnier, and J.P. Lecocq HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product Nature 330 1987 266
16. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29
17. F.M. Hecht, M.P. Busch, B. Rawal, M. Webb, E. Rosenberg, M. Swanson, M. Chesney, J. Anderson, J. Levy, and J.O. Kahn Use of laboratory tests and clinical symptoms for identification of primary HIV infection AIDS 16 2002 1119
18. A.D. Hoffman, B. Banapour, and J.A. Levy Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions Virology 147 1985 326
19. R. John, S. Arango-Jaramillo, S. Self, and D.H. Schwartz Modeling partially effective HIV vaccines in vitro J. Infect. Dis. 189 2004 616
20. M.S. Killian, J. Monteiro, J. Matud, L.E. Hultin, M.A. Hausner, O.O. Yang, P.K. Gregersen, R. Detels, J.V. Giorgi, and B.D. Jamieson Persistent alterations in the T-cell repertoires of HIV-1-infected and at-risk uninfected men AIDS 18 2004 161
21. F.A. Koning, C.A. Jansen, J. Dekker, R.A. Kaslow, N. Dukers, D. van Baarle, M. Prins, and H. Schuitemaker Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour AIDS 18 2004 1117
22. A.L. Landay, C.E. Mackewicz, and J.A. Levy An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status Clin. Immunol. Immunopathol. 69 1993 106
23. J.A. Levy HIV and the Pathogenesis of AIDS 1998 ASM Press
24. J.A. Levy The search for the CD8+ cell anti-HIV factor (CAF) Trends Immunol. 24 2003 628
25. J.A. Levy, C.E. Mackewicz, and E. Barker Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells Immunol. Today 17 1996 217
26. C. Mackewicz, and J.A. Levy CD8+ cell anti-HIV activity: nonlytic suppression of virus replication AIDS Res. Hum. Retrovir. 8 1992 1039
27. C.E. Mackewicz, H.W. Ortega, and J.A. Levy CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual J. Clin. Invest. 87 1991 1462
28. C.E. Mackewicz, H. Ortega, and J.A. Levy Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor Cell. Immunol. 153 1994 329
29. C.E. Mackewicz, L.C. Yang, J.D. Lifson, and J.A. Levy Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection Lancet 344 1994 1671
30. C.E. Mackewicz, D.J. Blackbourn, and J.A. Levy CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription Proc. Natl. Acad. Sci. U. S. A. 92 1995 2308
31. C.E. Mackewicz, E. Barker, and J.A. Levy Role of beta-chemokines in suppressing HIV replication Science 274 1996 1393
32. C.E. Mackewicz, E. Barker, G. Greco, G. Reyes-Teran, and J.A. Levy Do beta-chemokines have clinical relevance in HIV infection? J. Clin. Invest. 100 1997 921
33. C.E. Mackewicz, J. Lieberman, C. Froelich, and J.A. Levy HIV virions and HIV infection in vitro are unaffected by human granzymes A and B AIDS Res. Hum. Retrovir. 16 2000 367
34. J.B. Margolick, A.D. Donnenberg, A. Munoz, L.P. Park, K.D. Bauer, J.V. Giorgi, J. Ferbas, and A.J. Saah Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3-populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study J. Acquir. Immune Defic. Syndr. 6 1993 153
35. J.S. McDougal, S.P. Cort, M.S. Kennedy, C.D. Cabridilla, P.M. Feorino, D.P. Francis, D. Hicks, V.S. Kalyanaraman, and L.S. Martin Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy- associated virus (LAV) J. Immunol. Methods 76 1985 171
36. C.E. Metz Basic principles of ROC analysis Semin. Nucl. Med. 8 1978 283
37. A. Mittag, D. Lenz, A.O. Gerstner, U. Sack, M. Steinbrecher, M. Koksch, A. Raffael, J. Bocsi, and A. Tarnok Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets Cytometry, A 65 2005 103
38. A. Munoz, A.J. Kirby, Y.D. He, J.B. Margolick, B.R. Visscher, C.R. Rinaldo, R.A. Kaslow, and J.P. Phair Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes J. Acquir. Immune Defic. Syndr. Human Retrovirol. 8 1995 496
39. G.R. Pietroboni, G.B. Harnett, and M.R. Bucens Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro J. Virol. Methods 24 1989 85
40. T. Reichert, M. DeBruyere, V. Deneys, T. Totterman, P. Lydyard, F. Yuksel, H. Chapel, D. Jewell, L. Van Hove, and J. Linden Lymphocyte subset reference ranges in adult Caucasians Clin. Immunol. Immunopathol. 60 1991 190
41. P. Salmon, R. Olivier, Y. Riviere, E. Brisson, J.C. Gluckman, M.P. Kieny, L. Montagnier, and D. Klatzmann Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication J. Exp. Med. 168 1988 1953
42. G.J. Stewart, L.J. Ashton, R.A. Biti, R.A. Ffrench, B.H. Bennetts, N.R. Newcombe, E.M. Benson, A. Carr, D.A. Cooper, and J.M. Kaldor Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group AIDS 11 1997 1833
43. S.A. Stranford, J. Skurnick, D. Louria, D. Osmond, S.Y. Chang, J. Sninsky, G. Ferrari, K. Weinhold, C. Lindquist, and J.A. Levy Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response Proc. Natl. Acad. Sci. U. S. A. 96 1999 1030
44. S.A. Stranford, J.C. Ong, B. Martinez-Marino, M. Busch, F.M. Hecht, J. Kahn, and J.A. Levy Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection Proc. Natl. Acad. Sci. U. S. A. 98 2001 597
45. M. Tateno, and J.A. Levy MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV) Virology 167 1988 299
46. L.X. Truong, T.T. Luong, D. Scott-Algara, P. Versmisse, A. David, D. Perez-Bercoff, N.V. Nguyen, H.K. Tran, C.T. Cao, A. Fontanet, J.Y. Follezou, I. Theodorou, F. Barre-Sinoussi, and G. Pancino CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam AIDS 17 2003 1425
47. C.M. Walker, D.J. Moody, D.P. Stites, and J.A. Levy CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication Science 234 1986 1563
48. + cells varies among infected individuals Cell. Immunol. 119 1989 470
49. C.M. Walker, A.L. Erickson, F.C. Hsueh, and J.A. Levy Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism J. Virol. 65 1991 5921
50. L.D. Wiviott, C.M. Walker, and J.A. Levy CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture Cell. Immunol. 128 1990 628
51. S. Zanussi, C. Simonelli, M. D'Andrea, C. Caffau, M. Clerici, U. Tirelli, and P. DePaoli CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection Clin. Exp. Immunol. 105 1996 220